The entries of “Technologies made in Vienna” are displayed in the project language.
Technologies from Vienna
PhagoMed Biopharma GmbH
Certain infectious and parasitic diseases, diseases of the genitourinary systemPhagoMed Biopharma GmbH is an Austrian biotech company focused on the development of human therapeutic applications of phages and phage-derived proteins.
Currently, PhagoMed has three active development programs in the fields of periprosthetic joint infections, urinary tract infections and bacterial vaginosis.
These development programs are based on the experiences of its clinical co-founders with last-resort treatments, as well as research collaborations with highly renowned scientists and research institutions in Germany and Belgium.
Since its incorporation in November 2017, the company has raised more than €5.5 million in private investments and public grants.
PhagoMed has a team of eleven highly skilled scientist working on its programs, six of which at the Campus Vienna Biocenter in Vienna, Austria.
Kontakt Wirtschaftsagentur Wien
Information and networking are co-funded by the European Fund for regional development as part of the „IC3 Innovation by Co-Operation, Co-Creation and Community Building“ project. Additional information on the IWB/EFRE funding programme